Viguerie-Bascands N, Bousquet-Mélou A, Galitzky J, Larrouy D, Ricquier D, Berlan M, Casteilla L
CNRS URA 1937, UPS-IFR Louis Bugnard, Toulouse, France.
J Clin Endocrinol Metab. 1996 Jan;81(1):368-75. doi: 10.1210/jcem.81.1.8550779.
Brown adipose tissue (BAT) is involved in the control of energy balance and has been demonstrated to be activated through beta 3-adrenoceptor (beta 3-AR) occupation in rodents. The ability to specifically activate energy expenditure via this receptor is of great interest for the treatment of obesity. Nevertheless, the extent of BAT and the presence of a functional beta 3-AR in humans are now debated, and this situation is difficult to clarify for evident practical and ethical reasons. We investigated the occurrence of brown adipocytes in fat deposits of prepubertal baboons using antibodies raised against uncoupling protein (UCP) in Western blotting and immunocytology experiments. UCP was detected in all types of fat pads studied and was revealed in multilocular cells. Pericardiac and axillary adipose tissues displayed large amounts of UCP and can be assimilated to typical BAT. Most of the other pads looked like white adipose tissue, but exhibited areas with clusters of brown adipocytes and, thus, can be assimilated to the convertible adipose tissue as previously described in rodents. The presence of beta 3-ARs was evaluated by both beta 2-agonist-stimulated lipolysis and messenger ribonucleic acid (mRNA) expression studies. There was no significant lipolytic effect of any of the beta 3-AR agonists tested (SR 58611A, BRL 37344, CGP 12177, or CL 316243) in either white or brown tissues. PCR analysis demonstrated that beta 3-AR mRNA expression is not related to the UCP content of fat pads and that beta 3-AR expression is low. This study demonstrates the presence of great proportions of brown adipocytes in adipose tissue and the heterogeneity of the fat pads in baboons. The lack of a metabolic effect of beta 3-agonists combined with the weak expression of beta 3-AR mRNAs raise the question of the role of beta 3-ARs in adipose tissues of primates.
棕色脂肪组织(BAT)参与能量平衡的调控,并且在啮齿动物中已证实可通过β3-肾上腺素能受体(β3-AR)激活。通过该受体特异性激活能量消耗的能力对于肥胖症治疗具有重大意义。然而,目前关于人体中BAT的范围以及功能性β3-AR的存在存在争议,鉴于明显的实际和伦理原因,这种情况难以阐明。我们利用针对解偶联蛋白(UCP)产生的抗体,通过蛋白质免疫印迹法和免疫细胞化学实验,研究了青春期前狒狒脂肪沉积物中棕色脂肪细胞的存在情况。在所研究的所有类型脂肪垫中均检测到UCP,且在多泡细胞中得以显示。心包和腋窝脂肪组织显示大量UCP,可被视为典型的BAT。大多数其他脂肪垫看起来像白色脂肪组织,但呈现出棕色脂肪细胞簇集区域,因此可被视为如先前在啮齿动物中所描述的可转化脂肪组织。通过β2-激动剂刺激的脂肪分解和信使核糖核酸(mRNA)表达研究对β3-AR的存在进行了评估。在所测试的任何一种β3-AR激动剂(SR 58611A、BRL 37344、CGP 12177或CL 316243)作用下,白色或棕色组织均未出现明显的脂肪分解效应。PCR分析表明,β3-AR mRNA表达与脂肪垫的UCP含量无关,且β3-AR表达水平较低。本研究证明了狒狒脂肪组织中存在大量棕色脂肪细胞以及脂肪垫的异质性。β-激动剂缺乏代谢效应以及β3-AR mRNA表达较弱,引发了关于β3-AR在灵长类动物脂肪组织中作用的疑问。